| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
barda_industry_day [2023/03/01 09:31]
liam [Participants] | barda_industry_day [2023/03/02 07:24] (current)
liam [Participants] |
|---|
| | [[Troy Francis]] | Contracting Officer | [[Biomedical Advanced Research and Development Authority]] (BARDA) | | | [[Troy Francis]] | Contracting Officer | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | [[Gregory Frank]] | - | [[Biotechnology Innovation Organization]] (BIO) | | | [[Gregory Frank]] | - | [[Biotechnology Innovation Organization]] (BIO) | |
| | | [[Amie Franklin]] | CEO | [[medical_technology_companies:OxyBand Technologies]] | |
| | | [[Christopher Frech]] | SVP, Global Government Affairs | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[I.P. Freely]] | CEO | [[WonderWorks]] | |
| | | [[Douglas Freitag]] | Owner | [[Bayside Materials Technology]] | |
| | | [[Valerie Fremont]] | CSO | [[medical_technology_companies:Quality Biological]] | |
| | | [[Michael Friend]] | Principal Investigator | [[Intellectual Ventures Laboratory]] | |
| | | [[Bob Fritzen]] | - | [[medical_technology_companies:Caprion Biosciences]] | |
| | | [[Phyllis Frosst]] | Global Director of Health Policy | [[pharmaceutical_companies:Seqirus]] | |
| | | [[Jeffrey Froude]] | - | [[Defense Threat Reduction Agency]] (DTRA) | |
| | | [[Kate Fry]] | CEO | [[America's Blood Centers]] | |
| | | [[Robert Fuentes]] | Senior Director of Medical Information | [[pharmaceutical_companies:Novavax]] | |
| | | [[Nick Fullenkamp]] | Senior Director of Corporate Development | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[Ryan Fung]] | - | [[PRA Health Sciences]] | |
| | | [[Carrie-Lynn Furr]] | Vice President of Regulatory Affairs | [[pharmaceutical_companies:AmpliPhi Biosciences]] | |
| | | [[Joan Fusco]] | CDO | [[pharmaceutical_companies:Crozet BioPharma]] | |
| | | [[Rachel Fybel]] | - | [[United States House of Representatives]] | |
| | | [[Alexis Gabard]] | Director of Programs | [[pharmaceutical_companies:Keratin Biosciences]] | |
| | | [[Maryann Gallivan]] | President and CEO | [[Tunnell Consulting]] | |
| | | [[Yonghong Gao]] | Statistician (Biology) | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Neal Gapinski]] | Vice President | [[pharmaceutical_companies:CritiTech]] | |
| | | [[Efrain Garcia]] | Health Scientist | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Darin Gardner]] | Partner | [[Jochum Shore & Trssevin]] | |
| | | [[Joseph Gariano]] | Consultant | [[Core Solutions]] | |
| | | [[Michael Gayle]] | Business Development Manager - DoD Growth Market | [[SRI International]] | |
| | | [[Cohava Gelber]] | Executive Chairperson | [[pharmaceutical_companies:Serpin Pharma]] | |
| | | [[Bruce Gellin]] | President of Global Immunization | [[Sabin Vaccine Institute]] | |
| | | [[Amir Genosar]] | CEO | [[pharmaceutical_companies:Aktivax]] | |
| | | [[Dylan George]] | Associate Director | [[In-Q-Tel]] | |
| | | [[Sandra George]] | Director of Grants and Contracts | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[Joseph Gerstner]] | Vaccine and Biological Development | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Abdi Ghaffari]] | Vice President of Preclinical Research | [[pharmaceutical_companies:AIT Therapeutics]] | |
| | | [[Kaushik Ghosal]] | Director of Business Development | [[BioMotiv]] | |
